V8 Peptides — Engineered Performance
Research Library
NAD+ Biosynthesis: Precursor Routes and Assay Design
NAD+Chemistry

NAD+ Biosynthesis: Precursor Routes and Assay Design

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

How do cells make NAD+ from different precursors? Published work describes more than one route. Nicotinic acid and nicotinamide were classically defined as the vitamin precursors, with synthesis through nicotinic acid mononucleotide; nicotinamide riboside was later shown to be a precursor through its own kinases (Bieganowski and Brenner, 2004). In mammalian cells nicotinamide phosphoribosyltransferase (Nampt) was reported as the rate-limiting step of one pathway (Revollo et al., 2004), and extracellular NAD and NMN are degraded outside the cell into permeable precursors before conversion to cytosolic and mitochondrial NAD (Nikiforov et al., 2011). This guide maps those routes and the experiments that separate them: enzyme perturbation, labeled precursors and compartment-specific readouts. For laboratory research use only; see the NAD+ 1000 mg product page and NAD+ research overview.

NAD+ is a molecule that most cell-biology experiments touch indirectly, through sirtuins, PARPs and redox assays, and so its supply chain is easy to overlook. This article is about that supply chain: the routes by which cells make NAD+, how precursors are converted, and how a laboratory can tell which route a given manipulation uses. It is deliberately about pathway logic and assay design, in contrast with our product-comparison article on NAD+ versus NMN versus NR. The compound is supplied for laboratory research use only; not for human consumption.

What NAD+ is and why its synthesis is compartmentalized

NAD+ is a coenzyme in all living cells. It carries electrons in redox reactions and is a cosubstrate for enzymes such as sirtuins and poly(ADP-ribose) polymerases (Verdin, 2015). Unlike most items in the V8 catalog it is not a peptide but a dinucleotide, with a formula of C21H27N7O14P2 and a molecular weight near 663 g/mol, as described on the NAD+ 1000 mg product page. The consuming enzymes live in the nucleus, cytosol and mitochondria, so supply has to be organized by compartment: a genetically encoded biosensor study found that free NAD+ concentrations in the nucleus, cytoplasm and mitochondria approximate the Michaelis constants for sirtuins and PARPs in those compartments, and that depleting the enzymes of the final biosynthesis step revealed cell-specific mechanisms for maintaining mitochondrial NAD+ (Cambronne et al., 2016).

That is why a single total-NAD number from a cell lysate hides most of the biology. A pathway experiment needs to ask three things: which precursor is used, which enzyme converts it, and in which compartment the NAD+ ends up.

The routes, one at a time

Vitamin precursors and the nicotinic acid mononucleotide route. Nicotinic acid and nicotinamide were defined as the vitamin precursors of NAD+ in classic work, and the accepted view of eukaryotic NAD+ biosynthesis was that all anabolism flows through nicotinic acid mononucleotide (Bieganowski and Brenner, 2004).

The nicotinamide riboside route. Bieganowski and Brenner challenged that view experimentally and reported that nicotinamide riboside is an unanticipated NAD+ precursor in yeast, that nicotinamide riboside kinases from yeast and humans were essential for the pathway and highly specific for phosphorylation of nicotinamide riboside, and that the compound was found as a nutrient in milk (Bieganowski and Brenner, 2004). The route bypasses nicotinic acid mononucleotide, as the paper's title states.

The salvage route through Nampt. In mouse fibroblasts, Revollo and colleagues determined the kinetics of NAD biosynthesis mediated by Nampt and Nmnat, found that Nampt was the rate-limiting component, and showed that raising Nampt (but not Nmnat) increased total cellular NAD and enhanced the transcriptional regulatory activity of Sir2alpha (Revollo et al., 2004). This is the pathway most often manipulated in cells when a rate-limiting step is wanted.

NMN and NR as intermediates. A 2018 review discusses nicotinamide riboside and nicotinamide mononucleotide as key NAD+ intermediates and notes that their fates appear to depend on tissue distribution and expression of NAD+ biosynthetic enzymes, nucleotidases and presumptive transporters (Yoshino et al., 2018). In mammalian cells and mouse tissues, NR supplementation was reported to increase NAD+ levels and activate SIRT1 and SIRT3 (Cantó et al., 2012).

RouteEntry precursorKey enzyme or step named in the sourcesSource
Classical vitamin routeNicotinic acid; nicotinamideFlow through nicotinic acid mononucleotideBieganowski and Brenner, 2004
Nicotinamide riboside routeNicotinamide ribosideNicotinamide riboside kinasesBieganowski and Brenner, 2004
Nampt salvageNicotinamideNampt, rate-limiting; then NmnatRevollo et al., 2004
NMN-dependent mitochondrial synthesisPrecursors converted to NMN in cytosolNMNAT3 in the mitochondrial matrixNikiforov et al., 2011

From the medium to the mitochondrion

Nikiforov and colleagues built a detector for organellar NAD by targeting poly(ADP-ribose) polymerase activity into the mitochondrial matrix, so that immunodetectable poly(ADP-ribose) reported mitochondrial NAD availability. They reported that, besides nicotinamide and nicotinic acid, only the corresponding nucleosides readily enter cells, while nucleotides such as NAD and NMN undergo extracellular degradation to permeable precursors; these precursors can all be converted to cytosolic and mitochondrial NAD, with mitochondrial synthesis proceeding through NMN in the cytosol and then NMNAT3 in the matrix, which was localized to the mitochondrial matrix (Nikiforov et al., 2011).

The experimental consequence is important and often missed: adding NAD+ itself to a culture does not mean intact NAD+ enters the cell. The medium contains degradation activity, and what the cell receives may be precursors. A study that wants to interpret an effect must therefore include controls that distinguish intact NAD+ from its breakdown products, such as measuring the medium over time, and test the dependence on the enzymes that convert the precursors.

Assay design for pathway questions

Three families of experiment separate the routes. Enzyme perturbation: knockdown, knockout or pharmacological inhibition of a pathway enzyme (for example Nampt, NR kinases or NMNAT3) shows whether a precursor's effect depends on it. Revollo et al. used dose manipulation of Nampt and Nmnat in just this way. Labeled precursors: isotope-labeled nicotinamide, nicotinic acid or riboside-containing precursors, followed by mass-based detection of labeled NAD+ and intermediates, give a direct readout of flux through each route. Compartment-specific readouts: targeted biosensors (Cambronne et al., 2016) or the matrix-targeted PARP detector (Nikiforov et al., 2011) distinguish nuclear, cytosolic and mitochondrial pools.

Measurement itself needs care. NAD+ and NADH interconvert and are chemically labile, so extraction conditions that stabilize the oxidized and reduced forms separately are standard, and samples should be processed promptly and kept cold. A readout of the NAD+/NADH ratio is not the same as a total-NAD measurement, and either should be normalized to cell number or protein.

QuestionApproachControlPitfall
Does a precursor need enzyme X?Knockdown or inhibitor of XScrambled or vehicleIncomplete knockdown
Which route carries flux?Labeled precursor, mass-based readoutUnlabeled precursorIsotope scrambling through salvage
Which compartment gains NAD+?Compartment-targeted sensorSensor with non-responsive mutantSensor expression levels
Does exogenous NAD+ enter cells intact?Time course of medium and lysateHeat-inactivated mediumExtracellular degradation
Is total NAD the right endpoint?Measure NAD+, NADH and ratioSpiked recovery standardsOxidation during extraction

Handling the NAD+ research material

The NAD+ 1000 mg product page lists a 1000 mg size as lyophilized powder, formula C21H27N7O14P2, purity stated as at least 98%, stored at 2–8 °C or −20 °C long term, protected from heat, moisture and light; a COA is marked as coming soon, so check the page before relying on batch documentation. For a pathway experiment the concentration of the stock matters, because NAD+ is added to cultures across wide ranges; calculate with the molar mass and use the calculator, with the formula logic in reconstitution volume calculations adapted to a non-peptide solid. For quality background see NAD+ purity testing, for vial size considerations NAD+ 500 mg vs 1000 mg, and for general context what is NAD+. Documentation basics are on the COA page, and the full catalog is in the shop.

Because the medium degrades extracellular NAD, a prudent design records how long the compound sat in medium before use and compares freshly prepared solution against aged solution. Covarrubias and colleagues' review notes that NAD+ influences many cellular functions including metabolic pathways, DNA repair, chromatin remodeling, senescence and immune function (Covarrubias et al., 2021), which is why a change in NAD supply can have widespread secondary effects and why pathway-specific controls matter.

Frequently asked questions

What are the main routes to NAD+?

The sources describe the classical route through nicotinic acid mononucleotide, a nicotinamide riboside route using NR kinases, and a Nampt-dependent route from nicotinamide.

Is Nampt rate-limiting?

In the mouse fibroblast study, Nampt was the rate-limiting component of the Nampt/Nmnat pathway (Revollo et al., 2004).

Who showed that nicotinamide riboside is a precursor?

Bieganowski and Brenner reported it in yeast, identified the kinases involved and found it in milk (2004).

Does NAD+ enter cells intact?

The 2011 study reported that nucleotides like NAD and NMN are degraded extracellularly to permeable precursors, so intact entry should not be assumed.

Where is mitochondrial NAD made?

From NMN taken into the matrix, by NMNAT3, which was localized to the mitochondrial matrix (Nikiforov et al., 2011).

Why measure compartments separately?

Free NAD+ differs between nucleus, cytoplasm and mitochondria and approximates the Km of local consuming enzymes (Cambronne et al., 2016).

How can a lab tell which route a precursor uses?

Enzyme perturbation, labeled precursors and compartment-specific readouts, with matching controls.

What is the molecular formula of NAD+?

C21H27N7O14P2, per the product page, with a molecular weight near 663 g/mol.

Is NAD+ a peptide?

No. It is a dinucleotide, which is why peptide-oriented HPLC and reconstitution habits need adapting.

What does the product page state about storage?

Refrigerate at 2–8 °C, or −20 °C for long term, protected from heat, moisture and light.

Responsible research use

Everything on this page is offered for laboratory research use only; it is background reading for qualified researchers, not guidance for any use outside a research setting, and nothing here is a claim about benefit in people or animals. Products from V8 Peptides are sold strictly as research materials: not a drug, food or cosmetic, and not for human or animal consumption. Published studies described here were run by their authors under their own approvals and protocols, and this page does not recommend repeating them.

Related reading: NAD+ and Mitochondria: Respirometry and Mitonuclear Readouts, NAD+ in Axon Degeneration and Neurodegeneration Models, NAD+ Structure and Function: A Molecular Research Guide.

References

  1. Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208-1213. doi:10.1126/science.aac4854
  2. Bieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell. 2004;117(4):495-502. doi:10.1016/S0092-8674(04)00416-7
  3. Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem. 2004;279(49):50754-50763. doi:10.1074/jbc.M408388200
  4. Nikiforov A, Dölle C, Niere M, Ziegler M. Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem. 2011;286(24):21767-21778. doi:10.1074/jbc.M110.213298
  5. Cambronne XA, Stewart ML, Kim D, Jones-Brunette AM, Morgan RK, Farrens DL, et al. Biosensor reveals multiple sources for mitochondrial NAD+. Science. 2016;352(6292):1474-1477. doi:10.1126/science.aad5168
  6. Cantó C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, et al. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 2012;15(6):838-847. doi:10.1016/j.cmet.2012.04.022
  7. Yoshino J, Baur JA, Imai SI. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27(3):513-528. doi:10.1016/j.cmet.2017.11.002
  8. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141. doi:10.1038/s41580-020-00313-x

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.